
This fund is designed to deliver investment returns that closely reflect the performance of the Nifty 500 Index. Its primary objective is to track the movements of this benchmark, measured before any of the fund's own management fees or operational expenses are subtracted.
Is IND's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadli

Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit Before October 13 De

Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadli

Law Offices of Howard G. Smith reminds investors of the upcoming October 13, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of invest

[url="]Glancy Prongay Wolke and Rotter LLP[/url] reminds investors of the upcoming October 13, 2026 deadline to file a lead plaintiff motion in the class action f